Patents for A61P 39 - General protective or antinoxious agents (19,019) |
---|
11/17/2004 | CN1546016A Nanometer preparation of natural vitamin E and its preparation |
11/11/2004 | WO2004096950A1 Antioxidative composition |
11/11/2004 | US20040225123 Substituted phenyl naphthalenes as estrogenic agents |
11/11/2004 | US20040224314 G-protein coupled receptors |
11/11/2004 | DE19718245C5 Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung Synthetic triglycerides based on conjugated linoleic acid, processes for their preparation and their use |
11/11/2004 | CA2847543A1 Annatto extract compositions, including geranyl geraniols and methods of use |
11/10/2004 | EP1474445A1 Glycoisoforms of adiponectin and uses thereof |
11/10/2004 | EP1474395A1 Nicotinamide derivates useful as p38 inhibitors |
11/10/2004 | EP1474158A2 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
11/10/2004 | EP1474130A2 Use of compounds and compositions derived from olives for protecting cells against dna damage |
11/10/2004 | EP1207848B1 Purifying and/or regenerating agent |
11/10/2004 | EP1187854B1 Per(3,6-anhydro)cyclodextrin derivatives, preparation and use thereof for separating ions |
11/10/2004 | CN1545418A Method of increasing the presence of glutathione in cells |
11/10/2004 | CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof |
11/04/2004 | WO2004076349B1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto |
11/04/2004 | WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
11/04/2004 | US20040220133 Composition and method for inhibiting platelet aggregation |
11/04/2004 | US20040220117 Proteotoxin neutralizer |
11/04/2004 | US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders |
11/04/2004 | US20040219201 Tempamine compositions and methods of use |
11/04/2004 | US20040219181 Sustained release drug delivery devices with coated drug cores |
11/04/2004 | US20040219114 Cream for treatment of skin injured by the sun |
11/03/2004 | EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
11/03/2004 | EP1471933A1 Albumin-fused anti-angiogenesis peptides |
11/03/2004 | EP1471928A1 Hiv inhibiting proteins |
11/03/2004 | EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors |
11/03/2004 | EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
11/03/2004 | EP1471887A2 Nanoparticulate compositions having lysozyme as a surface stabilizer |
11/03/2004 | EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules |
11/03/2004 | CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them |
11/03/2004 | CN1173934C N-acetoacetarylamides |
11/02/2004 | US6812221 Immobilization |
10/28/2004 | WO2004092179A1 Spiro derivative, production process, and antioxidant |
10/28/2004 | WO2004092163A1 Phenylazole compound, production process, and antioxidant drug |
10/28/2004 | WO2004092153A1 Diamine derivative, production process, and antioxidizing drug |
10/28/2004 | WO2004069806A3 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
10/28/2004 | WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity |
10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
10/28/2004 | CA2522266A1 Phenylazole compound, production process therefor and antioxidant |
10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
10/27/2004 | EP1469882A2 Treatment of ms with goat serum |
10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
10/27/2004 | EP1237578A4 Micro-cluster liquids and methods of making and using them |
10/27/2004 | EP1037629B1 Combination of a retinoic acid metabolism blocking agent and a tocophereol |
10/27/2004 | CN1172687C Antifatigue health compsn. |
10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
10/26/2004 | US6809093 Drug resistance therapy |
10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
10/21/2004 | WO2004089354A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them |
10/21/2004 | WO2004032832A3 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
10/21/2004 | US20040209957 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
10/21/2004 | US20040209870 contain 5-HT ligands used to treat central nervous system disorders |
10/21/2004 | US20040208941 Compositions for removal of toxins |
10/21/2004 | DE202004012807U1 Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden Cosmetic and dermatological compositions with DNA repair enzymes and oligopeptides |
10/21/2004 | DE102004010690A1 Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten Health-promoting compositions of lipid-containing mushrooms and thiocyanates |
10/20/2004 | EP1468614A1 Method of improving the growth or the efficiency of feed conversion of an animal and composition for use therein |
10/20/2004 | EP1468019A2 Secreted protein |
10/20/2004 | EP1468018A2 Leptin proteins |
10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
10/20/2004 | EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
10/19/2004 | US6805887 Superoxide scavenger and beverage containing such |
10/14/2004 | WO2004087160A1 Treatment of neurological conditions |
10/14/2004 | WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages) |
10/14/2004 | WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives |
10/14/2004 | US20040204617 Solvent extraction to remove free radical of p-benzoquinone (p-benzosemiquinone) from cigarette; purification, crystallization and quantitative analysis |
10/14/2004 | US20040203045 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
10/14/2004 | US20040202624 Galenical formulation |
10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
10/13/2004 | EP1465642A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
10/13/2004 | EP1465577A2 Methods for improving the aesthetic appearance of skin |
10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
10/13/2004 | CN1536990A Pharmaceutical composition comprising (-)-secoisolariciresinol |
10/13/2004 | CN1170587C I (Robinia Pseudoacacia) lectin and its uses |
10/13/2004 | CN1170535C Use of medicine for treatment of migraikne by the administration of alpha-lipoic acid |
10/07/2004 | WO2004084916A1 Use of acetyl-d-aminoglycosamine in treatment of local lesions and systematic symptoms related to infections of virus or bacteria |
10/07/2004 | WO2004084914A1 Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals |
10/07/2004 | WO2004084906A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
10/07/2004 | WO2004084895A2 Modulation of cell death |
10/07/2004 | WO2004084876A2 Use of compounds for the prevention of drug-induced cell toxicity |
10/07/2004 | WO2004071639A3 Per (3,6-anhydro) cyclodextrine derivatives, production and use thereof in transporting metal elements to biological targets or in order to decontaminate biological fluids or targets |
10/07/2004 | US20040198841 Pretreatment before chemotherapy; antiulcer agents for cancer therapy |
10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
10/07/2004 | US20040198738 Preventives or remedies for diseaes caused by enos expression |
10/07/2004 | US20040198673 Composition for epigallocatechin gallate |
10/07/2004 | CA2560522A1 Use of compounds for the prevention of drug-induced cell toxicity |
10/07/2004 | CA2520403A1 Modulation of cell death |
10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
10/06/2004 | EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
10/06/2004 | EP1463756A2 Secreted proteins |
10/06/2004 | EP1463497A2 Treating muscle wasting with selective androgen receptor modulators |
10/06/2004 | EP1309309B1 Dermatological composition |
10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
10/06/2004 | CN1533776A Application of N-acetly glucosamine in the preparation of medicine for treating local injury and full body syndrome due to virus or bacterial infestation |
10/06/2004 | CN1533775A Application of N-acetylglucosamine in the preparation of medicine for treating viscera injure due to toxication from poison and medicine |